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The Tetraspanin Protein Peripherin-2 Forms a Complex with Melanoregulin, a
Putative Membrane Fusion Regulator
Abstract
Peripherin-2, the product of the rds gene, is a tetraspanin protein. In this study, we show that peripherin-2
forms a complex with melanoregulin (MREG), the product of the Mreg locus. Genetic studies suggest that
MREG is involved in organelle biogenesis. In this study, we explore the role of this protein in processes
associated with the formation of disk membranes, specialized organelles of photoreceptor rod cells.
MREG antibodies were generated and found to be immunoreactive with a 28 kDa protein in retinal
extracts, bovine OS, ARPE-19 cells, and rat RPE. MREG colocalized with peripherin-2 in WT (CB6F1/J) and
in rds+/- retinas. Western blots of serial tangential sections confirmed the close association of these two
proteins within the IS and basal outer segment of rods. Immunoprecipitation (IP) of OS extracts showed
formation of a complex between MREG and peripherin-2-ROM-1 hetero-oligomers. This interaction was
confirmed with pulldown analyses in which the GST-PerCter protein selectively pulled down His-MREG and
His-

MREG selectively pulled down PerCter. Biacore analysis using peptide inhibitors and per-2 truncation
mutant studies allowed us to map the MREG binding site on per-2 to the last five residues of the Cterminus (Gln341-Gly346), and kinetic data predicted a KD of 80 nM for PerCter-MREG binding. Finally, the
effect of MREG on photoreceptor specific membrane fusion was assayed using a disk-plasma membrane
cell free assay. Preincubation of target membranes with MREG resulted in a dose-dependent inhibition of
fusion with an IC50 in the submicromolar range. Collectively, these results suggest that this newly
identified protein regulates peripherin-2 function. © 2007 American Chemical Society.
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ABSTRACT:

Peripherin-2, the product of the rds gene, is a tetraspanin protein. In this study, we show that
peripherin-2 forms a complex with melanoregulin (MREG), the product of the Mreg locus. Genetic studies
suggest that MREG is involved in organelle biogenesis. In this study, we explore the role of this protein
in processes associated with the formation of disk membranes, specialized organelles of photoreceptor
rod cells. MREG antibodies were generated and found to be immunoreactive with a 28 kDa protein in
retinal extracts, bovine OS, ARPE-19 cells, and rat RPE. MREG colocalized with peripherin-2 in WT
(CB6F1/J) and in rds+/- retinas. Western blots of serial tangential sections confirmed the close association
of these two proteins within the IS and basal outer segment of rods. Immunoprecipitation (IP) of OS
extracts showed formation of a complex between MREG and peripherin-2-ROM-1 hetero-oligomers.
This interaction was confirmed with pulldown analyses in which the GST-PerCter protein selectively
pulled down His-MREG and His-MREG selectively pulled down PerCter. Biacore analysis using peptide
inhibitors and per-2 truncation mutant studies allowed us to map the MREG binding site on per-2 to the
last five residues of the C-terminus (Gln341-Gly346), and kinetic data predicted a KD of 80 nM for PerCterMREG binding. Finally, the effect of MREG on photoreceptor specific membrane fusion was assayed
using a disk-plasma membrane cell free assay. Preincubation of target membranes with MREG resulted
in a dose-dependent inhibition of fusion with an IC50 in the submicromolar range. Collectively, these
results suggest that this newly identified protein regulates peripherin-2 function.

Visual transduction, the conversion of incoming light to
an electrical signal, takes place in the outer segments of the
rod and cone photoreceptor cells. These highly specialized
polarized post-mitotic cells are divided into a specialized
inner segment region that is connected to the outer segment
by a ciliary axoneme. Rod photoreceptor outer segments
(OS)1 maintain constant length and normal function through
the coordination of disk morphogenesis and disk phagocytosis in a process known as photoreceptor renewal (1).
Peripherin-2 (also known as peripherin/rds), a photoreceptor
†
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specific tetraspanin protein, plays a critical role in disk
morphogenesis and stability (2, 3) as well as disk shedding
and phagocytosis (4-6); both processes require membrane
fusion (7). Evidence for the essential role of this protein was
established by a naturally occurring null mutation in the
retinal degeneration slow (rds) gene. Photoreceptors of rds
mice homozygous for the disrupted gene fail to produce OS
and undergo slow degeneration (8). In heterozygotes, the
ROS are reduced in length and irregularly arranged, consisting of whorls of membranous debris with abnormal disk
shedding (4-6, 8). The importance of peripherin-2 in OS
survival was further underscored by the finding that more
than 70 different mutations in peripherin-2 lead to autosomal
dominant retinitis pigmentosa and macular degeneration in
humans (RetNet, www.sph.uth.tmc.edu/Retnet). Interestingly,
in a double-knockout mouse, the loss of both peripherin-2
1
Abbreviations: MREG, melanoregulin; PerCter, peripherin-2 Cterminus; OS, outer segment(s); ROS, rod outer segment(s); IS, inner
segment(s); RPE, retinal pigment epithelium; GARP, glutamic acid rich
protein; R18, N′-octadecylrhodamine-5-thiourea; F18, N′-octadecylfluorescein-5-thiourea; PM, plasma membrane; rds, retinal degeneration
slow; GST, glutathione S-transferase; HA, hydroxylamine; SPR, surface
plasmon resonance; RSV, rim specific vesicle.
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and neural retina leucine zipper (Nrl-/-) transcription factor
results in altered disk assembly within cone photoreceptors
that lack normal OS lamellae. These photoreceptors were
still capable of phototransduction (9).
As a member of the growing tetraspanin family of
membrane proteins, peripherin-2 is 41% homologous in
sequence with NET-7, its nearest neighbor (10, 11). These
tetraspanning proteins have a short N-terminus, a large
hydrophilic loop (extracellular loop 2; EC2 domain) with
several distinctive cysteine motifs that are necessary for the
formation of functional oligomers (12-18). The EC2 domain
is the site of association between peripherin-2 and ROM-1
as well as with other peripherin-2 molecules (12-18).
Peripherin-2 is unique in this protein family in that it contains
the largest and most functionally diverse C-terminal region.
This subregion is intrinsically disordered (11) and contains
an incisure affinity domain (19), a membrane fusion domain
(20, 21), and an OS targeting domain (19, 22). Finally,
peripherin-2 links the disk rim to the cGMP-gated channel
of the plasma membrane through glutamic acid rich protein,
GARP, thereby stabilizing OS structure (23). Several studies
have suggested that the C-terminal domain of peripherin-2
has little structure and may belong to a family of proteins
with intrinsically disordered protein domains2,3 (11, 24).
Proteins belonging to this family contain structurally disordered regions that are highly conserved between species
and fulfill essential biological functions, although they lack
uniform secondary and tertiary structure (25). Structural
disorder is functionally significant because it allows for
increased plasticity in the regulation of multifunctional
proteins (26). In a murine model of retinitis pigmentosa, the
rds-307del model, the deletion of codon 307 in the peripherin-2 gene results in a gene product with an intrinsically
more ordered C-terminal domain characterized by an increase
in R-helical content. Retinal degeneration in this mouse is
more rapid than that observed in the rds homozygote (27).
In this study, we have identified a previously unknown
binding partner of peripherin-2, melanoregulin (MREG), and
demonstrate that this protein inhibits membrane fusion.
Melanoregulin is the product of the Mreg gene locus
[previously known as dilute suppressor (dsu) or whndependent transcript 2 (wdt2)] and is involved in the
regulation of murine coat color through an effect on the
transfer of melanosome to keratinocytes (28-33). MREG
suppresses the coat-color phenotype of three pigment mutations, dilute (d), ashen (ash), and leaden (ln) which encode
a melanosome transport system comprised of myosin 5A
(MYO5A), rab27a, and melanophilin (MLPH), respectively
(28, 33). MREG was positionally cloned and shown to alter
the incorporation of pigment into hair through a MYO5Aindependent pathway (34). The Mreg gene contains five
exons, encoding a small highly charged protein composed
of 214 amino acids, the sequence of which is highly
conserved between humans and mice (80% shared identity)
(27). The role of MREG in the visual system became
2
Edrington, V. T. C., Lapointe, R., Yeagle, P. L., Gretzula, C. A.,
and Boesze-Battaglia, K. (2006) Peripherin-2: An intracellular analogy
to viral fusion proteins, Biochemistry (submitted for publication).
3
Edrington, V. T. C., Yeagle, P. L., Gretzula, C. A., and BoeszeBattaglia, K. (2006) Calcium dependant association of calmodulin with
the C-terminal domain of the tetraspanin protein peripherin/rds,
Biochemistry (submitted for publication).

Biochemistry, Vol. 46, No. 5, 2007 1257
apparent in a series of genetic studies that evaluated the
interaction of a MREG loss of function mutation with various
coat color mutations. In two of these mutants, ruby (ru) and
ruby2 (ru2), the absence of melanoregulin expression suppressed the ruby eye color (31) by increasing the apparent
level of pigmentation in the choroid but not the RPE. Most
recently, the effect of MREG on eye color was shown to be
due to a role in regulating organelle biogenesis in the retinal
pigment epithelium and choroid, the function from which
the melanoregulin name is derived.4
Since disk membranes may be considered specialized
organelles, and it is well-known that peripherin-2 is essential
for disk assembly, we tested the hypothesis that MREG is
essential for peripherin-2-dependent function, specifically
fusion. The hypothesis that MREG participates in processes
requiring fusion is consistent with its effect on melanosome
transfer and pigment incorporation (35). In melanocytes, the
loss of MREG is postulated to alter melanosome phagocytosis, a process requiring fusion events (34). In this study,
we provide evidence that MREG colocalizes with peripherin-2 in ViVo in subcellular domains involved in vesicle
trafficking and disk morphogenesis (IS and basal OS).
Moreover, immunoprecipitation, pulldown, and surface plasmon resonance studies show formation of a complex between
MREG and peripherin-2-ROM-1 hetero-oligomers with
binding of MREG restricted to the C-terminus of peripherin2. Binding requires, at a minimum, the terminal five residues
of peripherin-2, Gln341-Gly346. Finally, MREG inhibits
disk-plasma membrane fusion in a dose-dependent manner,
suggesting a functional role for this protein in OS renewal
processes.
EXPERIMENTAL PROCEDURES
Materials
Rabbit polyclonal anti-FLAG antibody was purchased
from Sigma (F7425), rabbit polyclonal anti-actin Ab from
Santa Cruz (sc-10731), mouse monoclonal anti-sodium
potassium ATPase from Affinity BioReagents (MA3-924),
and anti-COX I from MitoSciences (MS404). Mouse antirhodopsin monoclonal antibody mAb4D2, anti-peripherin-2
mAb2B6, mAb3B6, mAb5H2, and anti-ROM-1 mAb1C6
were generous gifts from R. Molday (University of British
Columbia, Vancouver, BC). Monoclonal anti-MREG antibodies were generated in our laboratory as described below.
Two peptides, PP-5 and PP-3, corresponding to region within
the C-terminus of bovine peripherin-2 have been described
previously (18). PP-5 is a fusion inhibitory peptide corresponding to residues Val312-Leu326 and PP-3 to Gln331Glu346. The following cell lines were assessed for MREG
protein expression levels: RBL-2H3 chemically induced rat
basophils (ATCC, CRL-2256), mIMCD-3 mouse inner
medullary collecting duct cells (ATCC, CRL-2123), ARPE19 human retinal pigmented epithelium (ATCC, CRL-2302),
RPE-J rat retinal pigmented epithelium (ATCC, CRL-2240),
and primary cell cultures derived from mouse [MNT-1 (36)
and melan-c (37)].
4
Rachel, R. A., Nagashima, K., Lillo, C., O’Sullivan, N., Marigo,
V., Boesze-Battaglia, K., Williams, D. S., Copeland, N. G., and Jenkins,
N. A. (2006) Melanoregulin, product of the dsu locus, links the BLOCpathway and Oa1 in organelle biogenesis, (submitted for publication).
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Table 1: Primers Used in the Generation of the Bovine Peripherin-2 and ROM-1 Constructsa
mutant

primer

sequence

PerCter scrambled helix

P1 (F)
P2 (R)
P3 (F)
P4 (R)
P5 (F)
P6 (R)
P7 (F)
P8 (R)

TGGAGAAGAGCGTGCCGGAGGCCTGGGGGGCCACTCTGGAGAGTGTGAA
CTCCGGCACGCTCTTCTCCAGAAGCCAGCC
GTGTGAAGAAGCTGGGCAAGGACAACTACGTGCTAGCCGAGGGCGAG
CTTGCCCAGCTTCTTCACACTCTCCAGAGT
ATTAGGATCCCGGTACCTGCAGACAGCAC
ATTAGGATCCTCACTAGGCCTCAGGCAGACACTC
ACAAGGATCCATGGCGCTGCTGAAAGTCAAATTTGACCA
ATTAGGATCCTCAGCCTGCCGCCGGGGC

ROM-1Cter
PerNter
a

Forward (F) and reverse (R) primers are given.

Methods
Expression and Purification of GST-Polypeptide Constructs and Hexahistidine-Tagged MREG (His-MREG). The
GST-peripherin-2 fusion construct included the full-length
peripherin-2 C-terminus (Arg284-Gly346, GST-PerCter). In
addition, GST-peripherin-2 C-terminal substitution mutants
[PerCter scrambled helix, GST-peripherin-2 N-terminus, and
the GST-ROM-1 C-terminal construct with the full-length
ROM-1 C-terminus (Arg288-Ala351)] were prepared. PerCter
scrambled helix was obtained using a GeneTailor Mutagenesis System (Invitrogen) with the specific primers (Table 1),
according to the manufacturer’s protocol. The generation of
the GST-polypeptide constructs as well as the expression
and purification of these fusion proteins have been described
previously (24). Briefly, Escherichia coli BL21(DE3) cells
transformed with GST-polypetide constructs in pGEX-2T
vector (24, 38) were grown in LB medium containing 50
µg/mL ampicillin. Cells were harvested 2 h after induction
with 0.1 mM isopropyl β-D-thiogalactopyranoside (IPTG),
spun down, washed in PBS, and sonicated in the presence
of 35 mM octyl glucopyranoside (OG) in PBS (pH 7.2).
Cellular debris was removed by centrifugation, and the
GST-polypeptide constructs were purified on a GST affinity
column (Amersham Biosciences) and either cleaved with 400
units of thrombin (10 units of thrombin/mg of protein) for
use in surface plasmon resonance (SPR) studies or used as
an intact fusion protein in GST pulldown assays. The GSTEC2 protein contains a region encompassing Phe120-Asn256
and was a generous gift from M. Naash (39).
To generate an MREG fusion protein, Mreg cDNA was
cloned into a pIVEX 2.4 vector with an N-terminal hexahistidine tag, and the protein was expressed in Vitro using a
Rapid Translation System RTS 500 Proteomaster E. coli HY
Kit (Roche), according to the manufacturer’s protocol.
Coupled transcription-translation reactions were initiated
with the addition of 20 µg of Mreg construct in a total
volume of 1 mL for 24 h at 30 °C. His-MREG was purified
on chelating columns using the ÄTKA FPLC system
(Amersham Biosciences). Briefly, columns were loaded with
2.5 mL of 0.1 M NiSO4, washed with 5 mL of dH2O and
the product of each RTS reaction mixed with 4 mL of
binding buffer [0.02 M sodium phosphate, 0.5 M sodium
chloride, 20 mM imidazole, 35 mM OG, and 8 M urea (pH
7.4)], filtered, and loaded onto the prepared column. The
flow rate was set at 1 mL/min and the maximum pressure at
0.3 MPa. The column was washed with 50 mM imidazole
in elution buffer containing 0.02 M sodium phosphate, 0.5
M sodium chloride, 35 mM OG, and 8 M urea (pH 7.4) and
the protein eluted with 400 mM imidazole in elution buffer.
Samples were concentrated using a Centricon filter (Milli-

Table 2: Primers Used in the Construction of the Peripherin-2
C-Terminal Deletion Mutantsa

mutant primer
M1
M2
M3
M4
M5
M6
M7
a

P1 (F)
P2 (R)
P3 (F)
P4 (R)
P5 (F)
P6 (R)
P7 (F)
P8 (R)
P9 (F)
P10 (R)
P11 (F)
P12 (R)
P13 (F)
P14 (R)

sequence
AATATCTAGATCATGCCGCCGGGGCCT
GAGCGGATCCCGCTACCTGCACAC
GACGTCTAGATCACGCCGGGGCCT
GAGCGGATCCCGCTACCTGCACAC
GAGCTCTAGATCACGGGGCCTGGCCT
GAGCGGATCCCGCTACCTGCACAC
GATCTCTAGATCAGGCCTGGCCTGCGT
GAGCGGATCCCGCTACCTGCACAC
GAGGTCTAGATCACTGGCCTGCGTCCTC
GAGCGGATCCCGCTACCTGCACAC
GAGGTCTAGATCAGCCTGCGTCCTCGC
GAGCGGATCCCGCTACCTGCACAC
GAGGTCTAGATCATGCGTCCTCGCCCT
GAGCGGATCCCGCTACCTGCACAC

PCR
product
size (bp)
189
186
183
180
177
174
171

Forward (F) and reverse (R) primers are given.

pore) with a molecular mass cutoff of 10 kDa and dialyzed
in six changes of PBS containing decreasing amounts of urea
(4, 2, 1, and 0.5 M and 2 × no urea). The purity of
HisMREG was confirmed via 10% SDS-PAGE under
reducing conditions. Gels were stained using the SilverQuest
Silver Staining kit (Invitrogen), according to the manufacturer’s protocol, or transferred and immunoblotted. Blots
were probed with a 1:1000 dilution of either anti-MREG
mAb165 or mAb126, followed by a 1:1000 dilution of sheep
anti-mouse HRP-conjugated secondary antibody (Amersham
Biosciences).
Construction and Expression of Plasmids Containing
Deletion Mutations of the Peripherin-2 Gene. A construct
containing HisPerCter and a series of peripherin-2 C-terminal
deletion mutants, removing designated sequential amino
acids, HisPerCter∆346, HisPerCter∆345-346, HisPerCter∆344-346,
His
PerCter∆343-346, and HisPerCter∆342-346, were generated.
Each construct contained a RBS site and a T7 promoter
upstream of the respective gene and incorporated a hexahistidine N-terminal tag as well as an Xpress epitope. cDNA
sequences encoding the deletion mutants were obtained by
polymerase chain reaction (PCR) using the primers listed in
Table 2. Each resulting PCR fragment was inserted into the
multiple cloning sites of the pcDNA3.1 expression vector
(Invitrogen), and the plasmids were transformed into E. coli
JM109 cells. Transformed JM109 cells were grown in 1 L
of Luria Broth (LB) and utilized to purify the recombinant
plasmids for expression in MDCK cells as described previously (40). The authenticity of all constructs was confirmed
by sequence analysis.
Generation of Anti-MREG Monoclonal Antibodies. A
panel of anti-MREG monoclonal antibodies was generated
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for use in these studies. Briefly, recombinant His-MREG was
expressed in Vitro and purified by nickel affinity chromatography (41) as described above. Anti-MREG mAbs were
generated as previously described (42). Briefly, Balb/c mice
(Charles River Labs, Wilmington, MA), 10-12 weeks old,
were immunized by IP injection with 10-20 µg of His-MREG
on days 0, 10, 20, and 30 and allowed to rest for 30 days.
Three days prior to fusion, the animals received 10 µg of
peptide intravenously. Splenocytes were fused to Sp2/0-Ag14
myeloma cells in the presence of 50% polyethylene glycol
(Kodak 1450). The cells were then dispersed in Kennett’s
HY medium containing 20% FBS, glutamine, oxaloacetate,
pyruvate, hypoxanthine, and azaserine and fed 7 days later
in medium lacking azaserine. Clones were visible 7-9 days
after fusion and were first screened with a His-MREG ELISA.
All mAbs were further screened by dot blots and Western
blots using purified His-MREG as well as by immunofluorescence to determine which antibodies could recognize
MREG in ViVo. Two of these antibodies, anti-mouse mAb126
and mAb165, were further characterized and used in these
studies. These antibodies are essentially monospecific and
recognize His-MREG, as well as a 28 kDa band corresponding
to MREG in bovine ROS and human RPE in Western blots.
The distribution of MREG in the retina detected by antiMREG mAb126 and mAb165 was similar to that observed
with AP-33 (affinity-purified polyclonal antibody) generated
by J. Hammer (34).
Hydroxylamine (HA) Treatment of BoVine ROS. Darkadapted bovine retinas (Lawson, Lincoln, NE) were homogenized and rod outer segments (ROS) isolated by differential
centrifugation followed by discontinuous sucrose density
gradient separation (43). All procedures were carried out
under dim red light. Purified ROS (at 3 mg/mL total protein)
were incubated for 30 min at 37 °C with 1 M hydroxylamine
(HA) in 1 M Tris-HCl buffer (pH 7.0) (at a ratio of 50 µL
of ROS to 30 µL of HA) (44). HA-treated samples were
centrifuged at top speed for 5 min to separate proteins that
dissociated from the membrane fraction. Supernatant containing the dissociated proteins was collected and the pellet
resuspended in 30 µL of 10 mM HEPES (pH 7.4). Both
fractions were subjected to 12% SDS-PAGE under reducing
conditions and immunoblotted (45). Western blots were
probed with a 1:1000 dilution of mouse monoclonal antiMREG mAb165, followed by a 1:1000 dilution of sheep antimouse HRP-conjugated secondary antibody (Amersham
Biosciences). Digital analysis of blots was performed using
Kodak Image Station 440CF.
GST Pulldown Binding Assays. GST pulldown assays were
performed essentially as described previously (46). Purified
fusion protein was used for the pulldown assays within 24 h
of the preparation and attached to BaculoGold glutathioneagarose beads (BD Biosciences), according to the manufacturer’s specifications. The protein concentration was quantified with the BCA protein assay (Pierce Biotechnology).
After overnight incubation at 4 °C, beads were washed,
resuspended in 1 mL of 35 mM OG in PBS, and split into
two tubes. Either pure GST-polypeptide constructs, bovine
ROS, or the supernatant from hydroxylamine treatment of
ROS (∼1 mg of total protein), prepared as described above,
was added to the tubes. Following an overnight incubation,
the beads were washed and proteins were eluted with 1 mL
of 10 mM reduced glutathione in 50 mM Tris-HCl (pH 8.0).
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Samples were concentrated and proteins analyzed via 12%
SDS-PAGE and Western blotting. Blots were probed with
mouse monoclonal anti-peripherin-2 mAb2B6 (a generous
gift from R. Molday), anti-MREG mAb165, and sheep antimouse HRP-conjugated secondary antibody (Amersham
Biosciences).
Immunoprecipitation Studies. For immunoprecipitation (IP)
studies, 300 µL of 1 mg/mL mouse monoclonal anti-MREG
mAb165 antibody generated in our laboratory was bound to
400 µL of a 50% protein A-Sepharose bead slurry from
the Seize X immunoprecipitation kit (Pierce Biotechnology);
300 µL of 1 mg/mL MOP-C21-purified immunoglobulin
(Sigma) bound to 400 µL of protein A-Sepharose beads
was used as a negative control. Protein extracts were prepared
from purified ROS membranes isolated from bovine retinas
by centrifugation through a sucrose density gradient as
described previously (47). All procedures were carried out
under dim red light. The resultant OS membrane preparation
was solubilized in Triton X-100 and spun and the supernatant
assayed in the IPs. This bovine OS protein extract was preadsorbed on MOP-C21 bound to protein A-Sepharose beads
and subsequently incubated with either anti-MREG mAb165
or MOP-C21 antibodies along with protein A-Sepharose
beads, according to the manufacturer’s protocol (Pierce
Biotechnology). After an overnight adsorption at 4 °C, beads
were washed with 10 mM HEPES (pH 7.4) containing 300
mM NaCl and 0.02% sodium azide. Bound proteins were
eluted with elution buffer included in the Seize X immunoprecipitation kit and analyzed by gel electrophoresis and
immunoblotting with anti-peripherin-2 mAb2B6 or antiROM-1 mAb1C6.
R18 Fusion Assays. Bovine ROS disk and plasma membranes were prepared for fusion assays as described in detail
(48). Vesicles enriched with peripherin-2 and ROM-1 were
prepared essentially as described previously and were
designated rim specific vesicles (RSV) (20). Fusion between
R18-labeled OS plasma membrane vesicles and target membranes was carried out as described previously (49). Briefly,
ROS plasma membrane isolated using ricin-agarose as
described (50) was labeled with 3-5 mol % (relative to
phospholipid) octadecylrhodamine, R18, as described previously (48). The R18-labeled plasma membrane (R18-PM, 50
µL of 1 mg/mL total phosphate) was added to 3.0 mL of
the disk membrane suspension (1 mg/mL rhodopsin). The
increase in R18 fluorescence intensity as the PM fuses with
the disk membranes was measured over time. A linear
increase was observed for up to 30 min at 37 °C. In the
inhibition studies, disk membrane suspensions were preincubated with 1 nM to 10 mM His-MREG at 37 °C for 30
min prior to the addition of R18-PM and the initiation of
fusion. In this study, fusion is calculated as % fusion,
determined as the percent difference in the initial rate of
fusion between control samples and those containing fusion
inhibitor. Fusion kinetics were determined as described
previously (21, 51-53), with the lag time corresponding to
the time before an increase in R18 fluorescence is observed
indicative of membrane mixing and fusion (49). Non-fusion
specific peptides corresponding to the N-terminus of peripherin-2 or the extradiskal loop of peripherin-2 had no effect
on MREG-mediated inhibition of fusion.
Expression, Purification, and Fusion of Peripherin-2Containing COS-7 Cell Membranes Using Resonance Energy
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Transfer (RET) Fusion Assays. Procedures for the isolation
and cloning of bovine FLAG-peripherin-2 have previously
been described (54). Primer design was based on sequences
reported in refs 2 and 55. SV40 transformed kidney fibroblast
cells from the monkey Cercopithecus aethiops (COS-7) were
grown in Dulbecco’s modified essential medium (DMEM)
as per ATCC (American Type Culture Collection) recommendations. The cells were routinely split 1:3 every third or
fourth day. Transfections were performed using Lipofectamine PLUS reagent (Invitrogen). COS-7 cells seeded
in 15 cm culture dishes (3 × 107 cells/dish) were transfected
and harvested 48 h post-transfection, by scraping in 10 mL
of 10 mM HEPES (pH 7.4). The cells were resuspended in
4 mL of homogenizing buffer [100 mM monobasic sodium
phosphate, 1 mM DTT, 1 µg/mL leupeptin, and 2 µg/mL
aprotinin (pH 7.4)], pelleted (1000 rpm for 5 min), lysed by
being passed through a 26 gauge needle twice, and sonicated
three times for 10 s. Intracellular membranes from transfected
COS cells were isolated as described in ref 56 with slight
modification (54). Cell lysates were layered onto a singlelayer 30% sucrose gradient [30% (w/w) sucrose in homogenizing buffer] and spun at 25 000 rpm for 20 min at 4 °C
in a SW28 Beckman ultracentrifuge rotor. The plasma
membrane fraction was collected from the first interface and
pelleted by centrifugation (50 000 rpm for 30 min at 4 °C),
and membranes were resuspended in 1 mL of 10 mM HEPES
(pH 7.4). Membranes were labeled with 1 mol % F18 (N′octadecylfluorescein-5-thiourea, 1 mg/mL in ethanol) while
being vortexed and incubated at 37 °C for 30 min in subdued
light. Unincorporated label was removed with the addition
of 500 µL of 2% BSA being incubated for 10 min at 37 °C,
and labeled membranes were recovered by spinning at 50 000
rpm for 30 min at 4 °C. Pellets were resuspended in 500 µL
of 10 mM HEPES (pH 7.4) for fusion.
Assessment of MREG-Peripherin-2 Subunit Binding.
Surface plasmon resonance (SPR) studies were conducted
on a Biacore X instrument (Biacore AB, Uppsala, Sweden)
with active temperature control at 25 °C. The running buffer
for the experiments consisted of 10 mM MOPS, 60 mM KCl,
30 mM NaCl, 5 mM MgCl2 (pH 7.2), 3 mM EDTA, and 5
mM OG. Briefly, the flow rate was 50 µL/min, and the data
collection rate was set to high. Ni2+ was coupled to both
Fc1 and Fc2 of a NTA (nickel chelating surface) sensor chip
(Biacore BR-1004-07). Both flow cells were washed, and
the flow path to Fc1 was blocked and purified His-MREG
or PerCter allowed to bind to Fc2 until 2000 response units
(RU) was achieved. To characterize the interaction between
PerCter and MREG, the flow path was opened to include
both flow cells. Protein samples at the concentrations given
in the figure legends were serially diluted in the running
buffer and injected. Binding of MREG and PerCter to each
other was allowed to occur for 2 min, with the wash delay
set for an additional 2 min to allow for a smooth dissociation
curve. The chip surface was regenerated by injecting brief
pulses of 0.35 M EDTA until the response signal returned
to baseline. SPR data were analyzed with BIAevaluations,
version 3.0, which employs global fitting. Sensorgrams were
corrected for nonspecific binding by subtracting the control
sensorgram (Fc1) from the polypeptide-containing surface
sensorgram (Fc2). In all cases, the level of nonspecific
binding was determined and found to be between 12 and
20% of the total level of binding and subtracted with the
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use of the Fc1 sensorgram. Model curve fitting of individual
peptides was done with a 1:1 Langmuir binding model with
a drifting baseline. This is the simplest model for the
interaction between a receptor and a ligand; it follows the
equation A + B T AB. The rate of association (kon) was
measured from the forward reaction, and the dissociation rate
(koff) was measured from the reverse reaction. In lipid rich
membrane binding experiments, the membranes bound
nonspecifically to the HisPerCter sensor chip. Subtracting the
control sensorgram (Fc1) from the polypeptide containing
surface sensorgram (Fc2) corrected for nonspecific binding.
Routinely nonspecific binding accounted for 12-20% of total
binding, based on RU values.
Immunostaining. Immunohistochemistry was performed on
frozen sections of 4-month-old mouse retinas (57). The
eyecups were fixed in 4% paraformaldehyde in PBS (pH
7.4) for 4 h at 4 °C, cryoprotected in 30% sucrose, and
embedded in OCT. The 7 µm sections were doubly labeled
with either a 1:10 dilution of mouse anti-peripherin-2
mAb5H2 (gift from R. Molday) or a 1:1000 dilution of
mouse anti-sodium potassium ATPase antibody (Affinity
BioReagents) followed by 7 µg/mL goat anti-mouse Alexa
Fluor 647 secondary antibody (Invitrogen) and a 1:250
dilution of anti-melanoregulin mAb126 conjugated to Alexa
Fluor 594 (custom-made). The negative control was incubated with the secondary antibodies only. Nuclei were
visualized with DAPI. Images were captured on a Bio-Rad
Radiance 2100 laser scanning confocal microscope using the
same laser settings.
Immunoelectron microscopy was performed as described
elsewhere (58). Briefly, ultrathin sections were obtained from
LR White-embedded mouse (C57BL6) retinas and immunolabeled using an anti-MREG and anti-mouse secondary
antibody conjugated to 6 nm gold particles. The section was
doubly labeled with an anti-opsin rabbit polyclonal pAb01
and 12 nm gold particles conjugated to a secondary antibody
(59).
Western Blot Analysis of Serial Tangential Sections of the
Retina. Tangential sectioning of the retina was carried out
as previously described (60). Eyes were harvested from
2-month-old Long Evans rats and dissected in HEPESRinger’s solution [130 mM NaCl, 3.6 mM KCl, 2.4 mM
MgCl2, 1.2 mM CaCl2, 0.02 mM EDTA, and 10 mM
HEPES-NaOH (pH 7.4, osmolarity adjusted to 313 mosM)]
under a stereomicroscope as follows. The anterior portion
of the eye was cut away, and the lens was removed. The
eyecup with the retina attached was cut into several pieces
similar in size through the optic nerve. The eyecup fragment
was transferred to the flattening chamber, where the retina
was gently pulled away from the eyecup, and placed
photoreceptors up onto a PVDF membrane on a glass
capillary array (GCA 09/32/25/0/20 LM from BURLE
Electro-Optics, Sturbridge, MA). The retina was flattened
by applying gentle suction from underneath the glass
capillary array, removing the entire Ringer’s solution from
the flattening chamber. The retina, now attached to the PVDF
membrane, was additionally flattened when it was clamped
between two glass slides separated by 0.5 mm thick spacers
and frozen on dry ice. The cover glass and the spacers were
subsequently removed, and the retina was sectioned in the
Leica CM1850 Cryostat. The alignment of the retina surface
with the cutting plane of the microtome knife was performed
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as follows. Tissue freezing compound was applied to the
specimen holder of the microtome and allowed to freeze. It
was then sectioned through to create a flat surface large
enough to accommodate the base slide holding the frozen
retina. The base slide was then mounted to the freezing
compound by addition of water drops to the sides of the glass
base. The retina was trimmed to remove any folded edges,
and the remaining flat surface was cut in 5 µm serial sections,
each of which was thawed in 40 µL of sample buffer
containing 6 M urea, 125 mM Tris-HCl (pH 6.8), 4% SDS,
bromophenol blue tracking dye, and 10 mg/mL DTT.
Aliquots (15 µL) were separated on a 26-well 10% TrisHCl Criterion gel (Bio-Rad) and transferred to Immobilon
FL PVDF membrane (Millipore). For the detection of
rhodopsin, original samples were diluted 50 times. Western
blot analysis of the protein distribution in serial sections was
performed on an Odyssey Infrared Imaging System (LI-COR
Biosciences) using primary mouse monoclonal antibodies
against peripherin-2 (mAb3B6), melanoregulin (mAb126),
rhodopsin (mAb4D2), COX I (MS404, MitoSciences), and
secondary IRDye 680 goat anti-mouse antibody (LI-COR
Biosciences).
RESULTS
Complexes of Melanoregulin with Peripherin-2-ROM-1
Hetero-Oligomers. In our first series of studies, we sought
to determine if MREG was expressed in photoreceptor cells
and to identify photoreceptor specific binding partners of
MREG. To aid in these studies, we generated a series of
mouse anti-MREG monoclonal antibodies as described in
Methods. In these studies, we focused our analyses on a more
extensive characterization of mAb165. As shown in Figure
1A, this antibody is immunoreactive, with a 28 kDa protein
in human ARPE-19 cells and bovine retinal homogenates,
and a slightly higher band (approximately 30 kDa) is
observed in rat RPE-J cells. In addition, MREG was detected
in Madin Darby Canine Kidney (MDCK) cells and mIMCD-3 mouse inner medullary collecting duct cells, two highly
specialized polarized cell types. Finally, MREG was detected
in Jurkat cells but was absent from RBL-2H3 chemically
induced rat basophils, MNT-1 (primary mouse melanocytes),
and melan-C (nonpigmented mouse melanocytes) cells under
our immunoblotting conditions. Two of these antibodies,
mAb126 and mAb165, detected purified MREG expressed
in Vitro, as well as bovine MREG in purified ROS preparations by Western blot analysis (Figure 1B). Immunoprecipitation studies using anti-MREG mAb165 were preformed
to identify protein binding partners of MREG. Bovine OS
membrane protein extracts were immunoprecipitated with
anti-MREG mAb165. As shown in Figure 1C, a 33 kDa band
immunoreactive with anti-ROM-1 mAb1C6 and a 34 kDa
band immunoreactive with anti-peripherin-2 mAb2B6 were
observed. The anti-MREG mAb126 was not found to be
suitable for immunoprecipitation.
MREG Immunolocalization. We next analyzed the distribution pattern of MREG in wild-type (WT) CB6F1/J mouse
retinas using mAb126. As shown in Figure 2, MREG appears
to localize to the rod inner segment and distal portion of
OS, the site of disk morphogenesis (panel A) as well as the
RPE (panel B). RPE-associated MREG colocalizes with Na+/
K+-ATPase, an apical marker of these cells (see the arrow
in panel B, WT). Since anti-MREG mAb165 immunopre-
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cipitated a complex containing peripherin-2, we also assessed
the localization pattern of MREG in rds+/- and rds-/mouse retinas. In 4-month-old rds+/- retinas, MREG is
associated with the photoreceptor cell layer; in contrast, little
MREG is observed in the OS in the rds-/- retina.
Interestingly, MREG staining of the RPE in rds-/- is still
observed with some punctuate colocalization with Na+/K+ATPase (Figure 2B).
MREG Inhibits Fusion between Plasma Membrane and
Target Membranes in a Cell Free Assay System. The
immunoprecipitation studies and localization pattern of
MREG suggest that this protein may play a role in peripherin2-dependent function. Thus, we analyzed the effect of MREG
on peripherin-2-associated disk-plasma membrane fusion
processes using a cell free assay system (7, 20, 21). In these
studies, we investigated the effect of increasing concentrations of MREG (from 1 nM to 10 mM) on fusion between
purified OS plasma membrane (PM) and two different target
membranes, disk membranes and peripherin-2-ROM-1
enriched vesicles (RSVs). Membrane merger was followed
as an increase in fluorescence as R18-labeled ROS plasma
membranes (R18-PM) fuse with target membranes. Fusion
between R18-PM and RSVs was inhibited by more than 60%
upon addition of 10 mM MREG and by more than 40% when
added to R18-PM-disk-membrane assays (Figure 3). Addition of purified His-MREG inhibited fusion between R18PM and disk membranes with an IC50 of 1.5 × 10-6 M and
peripherin-2-ROM-1 enriched vesicles with an IC50 of 1.0
× 10-9 M. Finally, when MREG was added in combination
with the peripherin-2 fusion domain specific inhibitory
peptide, PP-5, fusion was almost completely abolished (data
not shown). These results suggest that MREG is a potent
fusion inhibitor at submicromolar levels.
The C-Terminus of Peripherin-2 Associates with Melanoregulin. The studies described above indicate that MREG
interacts with full-length peripherin-2 and inhibits membrane
fusion, a function associated with the C-terminus of peripherin-2. In the next series of experiments, we tested the
hypothesis that the C-terminus of peripherin-2 interacts with
MREG in pulldown assays. For these analyses, the Cterminus of peripherin-2 (residues Arg284-Gly346) was tagged
with an N-terminal GST tag. The GST-peripherin-2 fusion
protein (called, GST-PerCter) was expressed in E. coli as
described previously (24) and when purified exhibited the
predicted molecular masses, 30 kDa, for GST-PerCter
(Figure 4B, lane 3) and the GST-cleaved peripherin-2
C-terminus, 8 kDa (Figure 4B, lanes 1 and 2). The purified
PerCter polypeptide is biologically active. (1) It promotes
membrane destabilization and membrane fusion in model
systems. (2) It changes conformation in the presence of lipid
vesicles (24). (3) It targets to the OS in transgenic Xenopus
(19, 22, 61). Control GST-polypeptide constructs including
a GST-peripherin-2 C-terminus with a scrambled amphiphilic fusion helix (GST-PerCterScr.Helix), C-terminal
GST-EC2, and an N-terminal GST-tagged ROM-1 Cterminus (Arg287-Ala351) were expressed in E. coli (Figure
4C, lanes 4-6). Full-length MREG was tagged with an
N-terminal hexahistidine His-MREG, expressed in Vitro using
an RTS expression system, and purified to homogeneity,
corresponding to a 28 kDa band as shown in Coomassie bluestained gels in lane 1 of Figure 4C. The identity of the
polypeptide was confirmed by Western blotting using

1262 Biochemistry, Vol. 46, No. 5, 2007

Boesze-Battaglia et al.

FIGURE 1: Expression of MREG and immunoprecipitation from OS extracts. (A) Western blot of human ARPE-19 cells cultured and
isolated in the light, ARPE-19 (L), or in the dark, ARPE-19 (D), and rat RPE-J cells and bovine retinal homogenate immunoblotted with
anti-MREG mAb165. (B) Cell lysates from the indicated cell lines were also analyzed by Western blotting using anti-MREG mAb165. (C)
Western blot of purified ROS extracts, His-MREG, and E. coli-expressed GST fusion proteins using anti-MREG mAb126 and anti-MREG
mAb165. (D) Peripherin-2 interacts with MREG. Anti-MREG mAb165 was used to immunoprecipitate protein from ROS extracts, and the
IP products were detected with anti-rom-1 mAb1C6 or anti-peripherin-2 mAb2B6 as described in Methods.

mAb165 (Figure 4C, lane 2).
In the first series of pulldown studies, His-MREG, designated as the bait (Figure 4D), was incubated with purified
GST-polypeptide constructs as the prey. A 30 kDa protein
immunoreactive with anti-peripherin-2 mAb2B6 was pulled
down by His-MREG. GST alone did not interact with
His-MREG. No detectable binding with GST-PerCterScr.Helix,
GST-EC2, or GST-ROM-1Cter was observed in these
experiments (Figure 4D, lane 1). In reciprocal pulldown
assays, when GST-polypeptide constructs were used as the
bait (Figure 4E) and purified His-MREG was added as prey,
a 28 kDa protein immunoreactive with anti-MREG mAb165
was detected in the bait-prey complex with PerCter (Figure
4E, lane 1). In contrast, no MREG was detected if GSTPerCterScr.Helix, GST-EC2, or GST-ROM-1Cter was used
as bait. Finally, when purified PerCter was added to the

immobilized GST-PerCter as prey, no complex formation
was detected, and when His-MREG was added to His-MREG
as prey, no complex formation was detected (data not
shown). No nonspecific reactivity of anti-peripherin-2 mAb2B6
to His-MREG (Figure 4D lane 1) or anti-MREG mAb165 to
PerCter was detected (data not shown). These results suggest
that full-length MREG interacts with the C-terminus of
peripherin-2.
Kinetics of Formation of the MREG-Peripherin-2 Complex, a Surface Plasmon Resonance (SPR) Study. The kinetics
of formation of the MREG-PerCter complex was further
characterized by analyzing the thermodynamic binding
parameters of peptide interactions using Biacore. The Biacore
is an optical biosensor which detects changes in surface
plasmon resonance (SPR) in quantitatively measuring the
direct interaction between biomolecules in real time without
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FIGURE 2: (A) Immunolocalization of MREG in mouse retinas. Sections (7 µm) of fixed 4-month-old mouse WT (CB6F1/J), rds+/-,
and rds-/- retinas were stained with either anti-peripherin-2 mAb5H2 to mark outer segments (A) or anti-sodium potassium ATPase to
detect the apical region of RPE (B) followed by anti-mouse Alexa Fluor 647 secondary antibody (colored red) and double labeled with
anti-melanoregulin mAb126 conjugated to Alexa Fluor 594 (colored green). Nuclei were visualized with DAPI. Images were captured on
a Bio-Rad Radiance 2100 laser scanning confocal microscope (Bio-Rad) using the same laser settings: RPE, retinal pigment epithelium;
OS, outer segment; IS, inner segment; and ONL, outer nuclear layer. The scale bar is 5 µm. Arrows indicate colocalization of MREG and
sodium potassium ATPase.

FIGURE 3: MREG inhibition of R18 plasma membrane-target
membrane fusion. Fusion was assessed as an increase in R18
fluorescence over time as R18PM fuses with either disk membranes
preincubated with the indicated amounts of MREG at 37 °C for 30
min (O) or peripherin-2-enriched rim specific vesicles preincubated
with the indicated amounts of MREG (b). The amount of fusion
was measured at 37 °C as described in Methods and is presented
as the percent of the total fusion. Data represent two independent
experiments with fusion assays performed in triplicate.

the need for labels. In these studies, an N-terminal hexahistidine-tagged PerCter polypeptide (called HisPerCter, construct
shown in Figure 4A) was expressed in Vitro using an RTS
expression system and purified as described above for
HisMREG. HisPerCter was coupled to a sensor chip surface

[NTA (Ni2+)], and during the initial 50 s, a buffer baseline
was established. The sample was subsequently injected and
association of the sample with HisPerCter followed for 2 min
and dissociation of the complex followed for an additional
2 min as the sample was replaced with buffer. The data are
presented as a sensorgram, which shows response units (RU)
plotted as a function of time. In preliminary experiments,
we determined that there was very little nonspecific binding
(<10%) of the protein to the activated and blocked surface
on Fc1; nonetheless, data from Fc1 were subtracted from
the data from Fc2 to correct for changes in bulk refractive
index and nonspecific binding to the sensor chip surface.
Figure 5A shows a group of sensorgram overlays for the
binding of various components to immobilized HisPerCter.
The anti-peripherin-2 mAb2B6, the epitope of which corresponds to the terminal 12 residues of peripherin-2, binds
to the immobilized HisPerCter, suggesting that the bound
polypeptide assumes a native conformation. Since the
His
PerCter polypeptide changes conformation upon membrane
association (24), we wanted to determine if this conformational change resulted in measurable changes in RU. Thus,
we injected three lipid rich membranes, including purified
ROS membranes, OS plasma membrane, and vesicles
prepared from disk lipid extracts, onto immobilized
His
PerCter. As shown in the sensorgrams, when purified ROS
membranes were injected, an increase of >100 response units
was observed (Figure 5A). This result is in contrast with
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FIGURE 4: Construction, expression, and interaction of the GST-PerCter construct with MREG. (A) Schematic diagram showing the
structure of fusion proteins, hexahistidine-tagged peripherin-2 C-terminus (HisPerCter), hexahistidine-tagged MREG (His-MREG), and GSTtagged peripherin-2 C-terminus wild type and scrambled helix (GST-PerCter and GST-PerCterScr.Helix, respectively). (B) Coomasie bluestained gel (lane 1) showing expression of purified PerCter and Western blot analysis of purified PerCter using mAb2B6 (lane 2) and
GST-PerCter fusion protein using anti-GST (lane 3) as well as purified control GST-polypeptide constructs: GST-PerCterScr.Helix using
mAb2B6 (lane 4), GST-EC2 using anti-GST antibody (lane 5), and GST-ROM-1Cter using mAb1C6 (lane 6). (C) Coomasie blue-stained
gel of purified His-MREG (lane 1) and Western blot analysis of His-MREG fusion protein probed with anti-MREG mAb165 (lane 2). (D)
His-MREG interacts with PerCter. The His-MREG fusion protein attached to the Ni2+ resin was incubated with purified GST-polypeptide
constructs at 4 °C overnight as detailed in Methods. Interaction of MREG and the purified PerCter was verified by Western blot analysis
with the anti-peripherin-2 mAb2B6 (lane 1). The binding of the bait to the Ni2+ resin was confirmed using anti-MREG mAb165 (lane 2).
(E) The GST-PerCter fusion protein interacts with His-MREG. The GST fusion proteins attached to the glutathione resin were incubated
with purified His-MREG at 4 °C overnight as detailed in Methods. Interaction of MREG and the purified PerCter was verified by Western
blot analysis with the anti-MREG mAb165 (lane 1). The binding of the GST-polypeptide constructs to the glutathione resin was confirmed
using mAb2B6 (lane 2), mAb1C6 (lane 3), and anti-GST antibody (lane 4).

vesicles prepared from disk lipid extracts and plasma
membrane vesicles that showed no detectable change in RUs.
Collectively, these results suggest that HisPerCter binds ROS
membrane-associated protein(s) and that the change in RUs
is not due to a conformational change in HisPerCter since
such a change would be expected in the presence of all three
types of lipid vesicles.
Once we had established that the immobilized HisPerCter
assumes a native-like conformation, we injected purified
MREG in 2-fold serial dilutions over the loaded sensor chip.
Figure 5B shows a group of sensorgram overlays for the
binding of MREG (1.2-10 µM) to immobilized HisPerCter.
The lines represent the best global fits to a simple Langmuir

binding model with a drifting baseline, assuming that MREG
was a monomer in solution (34). Using this model, the P2
measures (a standard statistical measure for the closeness of
fit) were all below 10, and the residuals, which correspond
to the difference between actual and fitted data, are within
(5 RU, indicating a good fit (not shown). Assessment of fit
is important since the on and off rates are calculated from
the fitted data. Calculation of the affinity of MREG for
immobilized HisPerCter was (5.61 ( 1.27) × 10-9 M (KD,
Table 3), indicating the formation of a stable complex.
In a complementary series of studies, His-MREG was
immobilized on a sensor chip surface [NTA (Ni2+)] and
2-fold serial dilutions of the purified GST-PerCter polypep-
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FIGURE 5: Binding of MREG to PerCter assessed by surface
plasmon resonance. (A) Overlay of sensorgrams showing that
immobilized peripherin-2 interacts with MREG, OS extracts, and
a PerCter specific mAb, mAb2B6. PerCter does not interact with
vesicles or OS PM extracts. (B) Overlay of sensorgrams showing
the interaction of decreasing concentrations of MREG with immobilized PerCter. Data points were collected every 0.2 s. (C)
Representative overlay of sensorgrams showing the interaction of
decreasing concentrations of PerCter with immobilized MREG. The
thin arrow indicates the response with just GST without peripherin2. Data points were collected every 0.2 s.
Table 3: Kinetics and Affinity Values for Formation of the
MREG-PerCter Complex
immobilized
ligand

analyte

kon
(×103 s-1 M-1)

koff
(×10-3 s-1)

KD
(×10-9 M)

PerCter
MREG

MREG
PerCter

129 ( 14.8
128 ( 7.5

50.8 ( 7.25
107 ( 2.64

5.61 ( 1.27
80.4 ( 1.59

tide (Figure 4B, lane 3) were injected over the loaded sensor
chip (Biacore). As shown in Figure 5C, GST-PerCter bound
in a dose-dependent manner. GST added alone did not bind
to the immobilized MREG. As indicated above, the lines

represent the best global fits to a simple Langmuir binding
model with a drifting baseline, assuming that PerCter was a
monomer in solution (11, 62). Calculation of the affinity of
PerCter for immobilized His-MREG was (80.4 ( 1.59) ×
10-9 M (KD, Table 3), indicating the formation of a stable
complex. Analysis of the data indicates that the binding
kinetics for the formation of the complex was similar to that
observed when the molecules were in the reverse orientation
(KD, Table 3).
Mapping of the MREG Binding Site to the C-Terminus of
Peripherin-2. Once we established that the KD of MREGPerCter binding was in the nanomolar range, we proceeded
to map the region of the C-terminus that interacts with
MREG. In these peptide competition studies, we determined
which if any of a series of overlapping C-terminal peptides
(depicted in Figure 6A) inhibits complex formation using
SPR. An equimolar mixture containing purified MREG and
any one of the peptides (21) was injected onto the immobilized HisPerCter. The change in RUs between formation
of the MREG-HisPerCter complex in the presence of the
individual peptides is shown in Figure 6B. Only one peptide,
PP-3, inhibited binding between MREG and
His
PerCter, with a decrease of 60 RU. This peptide corresponds to the terminal 10 residues of peripherin-2, a region
containing the mAb2B6 epitope (2, 63). Analysis of the data
indicates that the binding kinetics for the competitive
inhibition of complex formation, Ki, of this interaction was
31 × 10-7 M. When the immobilized HisPerCter was
preincubated with PP-3 for 1 min prior to the addition of
MREG, similar results were obtained (data not shown). In a
complementary study, His-MREG was immobilized on the
chip surface and PP-3 added. Figure 6C contains a series of
overlaid sensorgrams showing that addition of PerCter
inhibits 50% of binding of PP-3 to His-MREG as evidenced
by the 2-fold decrease in the peptide’s RUs, confirming our
observation that MREG interacts with this region of PerCter.
A collective analysis of the results presented thus far
predicts that removal of the MREG binding domain would
affect peripherin-2-dependent fusion. This hypothesis was
tested with peripherin-2 deletion mutants peripherin-2∆336-346,
in which the terminal 10 residues are deleted, and peripherin2∆296-346, in which we deleted the entire C-terminus. The
full-length wild-type protein and the mutants were expressed
in COS-7 cells as described previously (54). Peripherin-2enriched membranes were isolated and labeled with F18, and
fusion with R18-PM vesicles was followed over time as
described in Methods using resonance energy transfer
techniques. In these studies, two kinetic parameters of fusion
were followed: the lag time of fusion, a time corresponding
to the length of time it takes to assume a fusion competent
form of peripherin-2, and the rate of fusion, an inherent
measure of peripherin-2 fusogenicity. As shown in Figure
6E, the peripherin-2∆336-346 mutant had the shortest lag time,
e10 s, while the full-length peripherin-2 exhibited a lag time
of >10 s. Coupled with this decreased lag time, an increase
in the initial rate of fusion (IRF) also was observed with the
peripherin-2∆336-346 mutant (Figure 6D).
In this final series of SPR studies, we mapped the minimal
binding domain of MREG to HisPerCter with a series of
His
PerCter truncation mutants. These mutants were designed
to delete the terminal seven residues of the C-terminus of
peripherin-2, one at a time. HisPerCter deletion mutants were
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FIGURE 6: Identification of a region of PerCter that binds MREG using peptide competition studies. (A) C-Terminal domain of bovine
peripherin-2 corresponding to residues 289-346. Regions 1-3 represent R-helical domains as predicted by Chou-Fasman analysis (54).
The series of overlapping peptides used in the competition studies is given. (B) Binding of PerCter to MREG is inhibited by PP-3, a peptide
corresponding to the terminal 10 residues of peripherin-2. The binding of PerCter preincubated with the indicated peptides to immobilized
MREG was followed using SPR as described in Methods. RU changes upon the addition of individual peptides are shown. Data represent
three independent binding studies, each of which was carried out in duplicate. (C) Representative sensorgrams of PP-3, PerCter, and an
equimolar mixture of PP-3 and PerCter, binding to immobilized MREG. Fusion of R18 plasma membrane with target membranes containing
peripherin-2 mutants. (D) Fusion between R18PM and purified F18-labeled COS-7 cell membranes enriched with full-length FLAG-peripherin-2
(black), FLAG-per2∆336-346 (gray), or FLAG-per2∆296-346 (white) was assessed as an increase in R18 fluorescence over time at 37 °C as
described in Methods. Data represent two independent experiments with fusion assays performed in triplicate. (E) Lag time of fusion
between R18PM. The time prior to a linear increase in R18 fluorescence indicative of membrane fusion is plotted for the fusion reactions
shown in panel D.

expressed in Vitro and purified exactly like full-length
His
PerCter. HisPerCter deletion mutants were individually
immobilized on the sensor chip surface, and the binding of
MREG was followed as described above. Figure 7 shows
overlaid sensorgrams of the individual HisPerCter deletion
mutants, HisPerCter∆346, HisPerCter∆345-346, HisPerCter∆344-346,
His
PerCter∆343-346, and HisPerCter∆342-346, and MREG. The
His
PerCter∆346 bound to the MREG almost as well as the wildtype HisPerCter. Binding of MREG to HisPerCter was completely abolished upon deletion of the last five residues of
the peripherin-2 C-terminus, in the PerCter∆342-346 mutant.
Deletion of the sixth (PerCter∆341-346 mutant) and seventh
(PerCter∆340-346 mutant) residues yielded results similar to

those for the PerCter∆342-346 deletion (data not shown).
Collectively, the SPR studies confirmed the in Vitro pulldown
assays showing association of HisPerCter with MREG; they
provided additional details about the kinetics of this process,
showed high-affinity complex formation with a KD on the
order of nanomolar, and have allowed us to partially map
the site of MREG-peripherin-2 interaction to the terminal
five residues of HisPerCter.
Membrane Affinity of Melanoregulin. Although peripherin-2 is a well-characterized membrane protein, the disposition of MREG in OS is unknown. On the basis of its
localization pattern and membrane fusion inhibitory function,
we hypothesized that MREG is loosely associated with ROS
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FIGURE 7: Terminal five residues of PerCter required for MREG
binding. Shown is an overlay of sensorgrams showing the interaction of wild-type PerCter and five PerCter mutants, HisPerCter∆346,
HisPerCter∆345-346, HisPerCter∆344-346, HisPerCter∆343-346,and HisPerCter∆342-346
with immobilized MREG. Data points were collected every 0.2 s.

membranes or membrane proteins. To test this hypothesis,
purified bovine ROS membranes were treated with hydroxylamine hydrochloride (HA-HCl) (44), allowing previously
associated proteins to be released into the supernatant. As
shown in Figure 8A, a 28 kDa band immunoreactive with
anti-MREG mAb165 was detected in the supernatant fractions of HA-treated ROS membranes. No detectable immunoreactivity was observed in the membrane rich pellet
fraction (Figure 8A, lane 2). To determine if this soluble
MREG forms a complex with GST-PerCter, the supernatant
fraction from HA-treated ROS was used as the prey in GST
pulldown studies as described in the legend of Figure 4. As
shown in Figure 8B (lane 2), GST-PerCter pulls down
MREG isolated in the HA-treated ROS supernatant. No
detectable MREG was associated with the GST-PerCter
complex in the absence of HA (Figure 8B, lane 1).
To determine if soluble MREG affects cell-free fusion,
we followed fusion between HA-treated disk membranes and
R18-PM (Figure 8C). Hydroxylamine-treated disk membranes
had 2-fold higher initial rates of fusion than untreated disk
membranes. When MREG, recovered in the HA supernatant
(Figure 8A), was added back to the disk membranes, fusion
inhibition was restored. Finally, when purified MREG was
added to the HA-treated disk membranes (MREG-stripped
membranes), inhibitory function was again restored (Figure
8C). Collectively, these results suggest that MREG functions
as a fusion inhibitor in Vitro; its mechanism of action may
be regulated by its association with either the membrane
through acylation or other proteins in a fusion complex. At
present, studies aimed at addressing these questions are
underway.
Subcellular Localization of MREG. Crucial for understanding the role of MREG in modulating peripherin-2
function is knowledge of its subcellular localization in rods.
Immunostaining studies shown in Figure 2 suggest colocalization between peripherin-2 and MREG specifically within
the IS and basal disk region. In this next series of studies,
we analyzed the subcellular distribution of MREG using
serial tangential sectioning of flat-mounted frozen retinas
coupled with Western blot analysis of proteins of interest in
each section. In this approach, the subcellular localization
of proteins of interest in the rod is determined by comparing
its distribution in the sections with the distribution of protein
markers confined to specific subcellular compartments. A

FIGURE 8: Membrane disposition of MREG in ROS membranes
and association of soluble MREG with PerCter. (A) Western blot
analysis of untreated ROS membranes and ROS pellets and
supernatants treated with HA as indicated. Blots were probed with
anti-MREG mAb165. (B) PerCter interacts with soluble MREG.
The GST-PerCter fusion protein attached to the glutathione resin
was incubated with either the pellet or the supernatant fraction from
HA-treated ROS. Samples were incubated at 4 °C overnight as
detailed in Methods. Interaction of MREG and the purified PerCter
was verified by Western blot analysis with anti-MREG mAb165.
(C) Fusion was assessed as an increase in R18 fluorescence over
time as R18PM was incubated with either untreated disk membranes
(designated -HA), HA-treated disk membranes (designated +HA),
disk membranes incubated with MREG containing HA supernatant
(designated HA sup), or disk membranes preincubated with pure
MREG (designated pure MREG). Fusion was assessed at 37 °C as
described in detail in Methods. Data represent two independent
experiments with fusion assays performed in triplicate.

representative experiment using this technique is shown
Figure 9. The distribution of peripherin-2 and MREG
throughout the serial sections obtained from the retina of a
dark-adapted rat was compared with the distribution of the
rod outer segment marker, rhodopsin, and the inner segment
marker, subunit I of cytochrome c oxidase, COX I, a
mitochondrially encoded protein present in the ellipsoid part
of the inner segment densely populated with mitochondria.
Our data indicate that MREG is enriched in sections
corresponding to the rod inner segment (Figure 9B, sections
7-9) and basal-most disks (sections 5-7). Peripherin-2 was
uniformly distributed along the length of the outer segment
(sections 2-7) and also observed in MREG rich regions,
including the inner segment and basal disks. Finally, the
distribution of MREG within photoreceptors was further
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FIGURE 9: Analysis of protein distribution in the retina by Western blotting of serial tangential sections. (A) Thin rat retina cross section
counterstained with toluidine blue (courtesy of A. Michaud, Massachusetts Eye and Ear Infirmary, Boston, MA). Retinal layers are as
follows: ROS, rod outer segments; RIS, rod inner layer. (B) Rat retina was flat-mounted, frozen, and serially 5 µm sectioned. The protein
content of each section was analyzed by Western blotting using antibodies against proteins indicated on the left of each blot. (C) Fluorescence
of MREG (b) Per 2 (O) and rhodopsin (‚ ‚ ‚) bands in each section plotted as a percentage of a combined fluorescence in all sections. The
data are taken from one of three similar experiments.

refined by immunoEM. ImmunoEM was performed with
either anti-MREG mAb-126 or mAb-165; both antibodies
labeled the inner segments with a similar pattern, suggestive
of IS vesicle labeling with no appreciable label in the OSs
(Figure 10A). Labeling with mAb165 was detected over
some inner retinal cells. Double labeling with opsin antibody
and either MREG antibody indicated that the MREG label
did not colocalize with opsin-containing vesicles in the inner
segment (Figure 10B).
DISCUSSION
The most divergent region within the tetraspanin family
of proteins, the C-terminal domain, may also confer functional specificity to these proteins (10). The C-terminus of
peripherin-2 alone has numerous unique functions in photoreceptor cells. At one level, the multifunctionality of
peripherin-2 is most likely due to the formation of homooligomers and hetero-oligomers with ROM-1. Recent evidence suggests that functional plasticity is conferred by the
intrinsically disordered nature of the C-terminus, resulting
in the association of peripherin-2 with other numerous ROS

proteins (23, 64). Since it functionally differs from the base
to the tip of the outer segment, one may expect the
association of peripherin-2 with various regulatory proteins
to be transient along the length of the OS.
This investigation uses a combination of GST pulldowns
and surface plasmon resonance to assess formation of the
peripherin-2 complex with a newly identified 28 kDa protein,
melanoregulin, in Vitro and immunoprecipitation studies to
analyze complex formation in ViVo. Collectively, these
studies suggest that MREG binding requires an intact
peripherin-2 C-terminus. In our studies, MREG did not
appear to associate with the C-terminus of ROM-1. Biacore
studies not only confirmed the formation of a MREGperipherin-2 complex but also provided us with sensitive
detection of molecular interactions in real time. The constant
for binding of peripherin-2 to immobilized MREG was (80.4
( 1.59) × 10-9 M, and that for the association of MREG
with peripherin-2 was (5.61 ( 1.27) × 10-9 M. This
variability in binding affinity is most likely due to the
conformation of MREG on the chip. We anticipate that
peripherin-2 is likely in a native conformation since periph-
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FIGURE 10: Immunogold labeling of MREG and rhodopsin in mouse photoreceptors. Ultrathin sections of LR White-embedded wild-type
C57BL6 mouse retina, immunogold labeled with anti-MREG mAb126 antibody (6 nm gold particles) and anti-opsin antibody (12 nm gold
particles). (A) Section labeled with the MREG antibody. Clusters of label are evident throughout the inner segments (bottom portion). The
outer segments (top portion) are not labeled. The scale bar is 1 µm. (B) Higher magnification of a section double labeled with both MREG
and opsin antibodies. The area shown is at the base of the cilium; the basal bodies are evident. The arrows point to single gold particles
indicating opsin labeling. The opsin labeling and melanoregulin labeling do not coincide. The scale bar is 300 nm.

FIGURE 11: Schematic representation of peripherin-2-MREG binding. The binding of MREG to the terminal five residues of human
peripherin-2 is illustrated. MREG is colored purple and the peripherin-2 fusion domain yellow.

erin-2 binds mAb2B6 and prior to loading the polypeptide
was shown to be biologically active, as defined by promotion
of both membrane destabilization and model membrane
fusion (data not shown). Therefore, we conclude that the
value of (5.61 ( 1.27) × 10-9 M is a more accurate reflection
of the binding constant and MREG binds to peripherin-2 with
high affinity. The decrease in affinity observed when MREG
was immobilized was largely due to an increase in koff (Table
3), indicating a destabilized heteromeric complex. The high
affinity binding constant is consistent with the dose-dependent inhibition of fusion seen in Figure 3. Fusion of plasma
membrane with disk membranes was inhibited with an IC50

of 1.5 × 10-6 M and with peripherin-2-ROM-1 enriched
vesicles with an IC50 of 1.0 × 10-9 M. These data strongly
suggest that the in Vitro association between MREG and
PerCter correlates with peripherin-2 functionality.
Using SPR technology, we found that MREG binds to the
terminal 10 residues of peripherin-2 with a minimal requirement for the last five, as shown schematically in Figure 11.
The specificity of binding to the C-terminus was confirmed
in the GST pulldown analyses in which no binding was
observed using GST-EC2 polypeptides or GST-ROM-1
C-terminal peptides. Of note is the lack of binding of MREG
to a peripherin-2 polypeptide containing a scrambled helical
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domain. This helical domain roughly corresponds to residues
309-329, not directly within the MREG binding domain.
Although this region is not the MREG binding site, we
predict that mutations of this region result in a structure that
is either more intrinsically ordered, thus prohibiting foldinginduced conformational changes, or more intrinsically disordered, thereby prohibiting MREG binding completely.
NMR studies aimed at distinguishing between these two
mechanisms are underway. Numerous studies of intrinsically
disordered proteins suggest that structural disorder is functionally significant because it allows for increased plasticity
in the regulation of multifunctional proteins (65-67).
Advantages of such plasticity include an increased propensity
to bind to several partners as well as an ability to overcome
steric restrictions, thereby allowing for a larger surface for
interactions between several different binding partners (26).
Many IDPs undergo a transition to more ordered states or
fold into stable secondary or tertiary structures upon binding
to a physiological partner, a process termed induced folding,
or coupled folding and binding (36). NMR studies conducted
in our laboratory support a similar induced folding transition;
PerCter becomes intrinsically more ordered through the
formation of an R-helical domain in the presence of
membrane mimetics.2 In addition, more recent work in our
laboratory demonstrates binding between calcium/calmodulin
and peripherin-2 within this intrinsically disordered Cterminal domain.3
Since our goal was to understand how MREG alters
peripherin-2 functionality, we assessed its role in membrane
perturbing functions of peripherin-2. We have previously
shown that peripherin-2 is a potent photoreceptor specific
fusogen, with a C-terminal amphiphilic helical domain of
residues Val311-Leu325 (20, 21) implicated in membrane
fusion as well as targeting of peripherin-2 to Xenopus OS.
Using a well-characterized cell free assay system designed
to mimic in ViVo photoreceptor specific fusion, MREG was
shown to inhibit fusion between PM and two distinct target
membranes, disk and peripherin-2-ROM-1 enriched vesicles.
Moreover, when the MREG binding domain is deleted from
the Per∆336-346 mutant, fusion with PM is enhanced. This
enhancement is most likely due to the formation of a fusion
competent conformation as reflected in the substantial
decrease in fusion lag time observed with this mutant (Figure
7). Finally, the association of MREG with a peripherin-2ROM-1 hetero-oligomeric complex has implications for
peripherin-2-dependent trafficking and OS stability. Since
MREG is localized to the IS and basal OS (Figures 9 and
10) and the site of disk morphogenesis and ROM-1 is
required for OS viability and disk morphogenesis as illustrated in the ROM-1 knockout mouse (68), we propose
that these two proteins may provide a regulatory mechanism
for proper disk formation and disk closure during morphogenesis.
Finally, studies addressing how hydroxylamine treatment
of disk membranes affects fusion provide insight into the
mechanism of this regulation. Although MREG shows no
sequence homology with any other protein, it contains a
putative C-terminal palmitoylation site. While deacylation
of MREG and membrane association was not addressed
directly when disk membranes were stripped of loosely
associated protein with the addition of HA, a substantial
increase in the rate of fusion was observed, suggesting the
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removal of a fusion inhibitor. In add-back experiments, the
addition of the supernatant fraction or pure MREG to the
stripped disk membranes decreased the extent of fusion,
suggesting that the fusion inhibitor had been restored.
Therefore, we hypothesize that MREG is a transient fusion
inhibitor with its regulatory role controlled by membrane
association.
Given the multifunctional nature of peripherin-2, the
formation of a peripherin-2-MREG complex may have other
as yet undetermined consequences for photoreceptor viability
and function. MREG may act as an additional linker protein
between GARP and the cyclic GMP-gated channel. The
tethering of GARP to peripherin-2 is predicted to result in a
circular arrangement of the cGMP-gated channel, in juxtaposition to the disk rim. The distance of approximately 10
nm between the disk rim and the plasma membrane is not
readily traversed if GARP assumes a globular conformation.
Previous studies (69) suggest that GARP-1 and GARP-2 in
their native state are intrinsically unfolded, thus allowing
them to span most of this distance. In addition, these authors
propose that a second as yet unidentified protein may help
to fill the gap.
The terminal 10 residues of peripherin-2 make up part of
the putative binding site(s) for both MREG and GARP (69).
However, these two observations are in no way mutually
exclusive when we consider the unique functional organization of disk components along the length of the outer
segment. The OS contains multifunctional regions: OS base,
site of new protein delivery and disk morphogenesis; midregion, primary site of phototransduction; and OS tip, the
site of disk packet formation and shedding. As is true of
other disk membrane-associated proteins, peripherin-2 remains associated with a disk once assembled and travels up
the length of the outer segment in that disk. Therefore, the
idea that various protein components, both soluble and
membrane-anchored, transiently bind to and associate with
peripherin-2 at distinct regions along the OS remains
intriguing and is supported by the serial tangential sectioning
studies described here (Figure 9). Although not tested to date,
the role of MREG as a regulator of membrane fusion
processes is consistent with its effect on melanosome transfer
and pigment incorporation (35). In melanocytes, the loss of
MREG is postulated to alter melanosome phagocytosis, a
process requiring fusion events (34).
Finally, these studies provide seminal evidence supporting
a role for the peripherin-2-MREG complex in disk assembly. The two proteins colocalize within the inner segment
and basal outer segment domains of the rod cell, in WT
C57BL6 mice, with the MREG distribution apparently
enriched in vesicle-like structures within the IS and connecting cilium. Double labeling experiments suggest that this
vesicle population did not contain opsin (data not shown).
While this is not shown directly in these studies, we postulate
that the MREG-containing vesicles transport peripherin-2ROM-1 complexes. The transport of these two rim specific
proteins has been observed as being independent of opsin
transport. In addition, Tam et al. (19) hypothesized that in
transgenic Xenopus the transport of peripherin-2 likely
required a protein cofactor. On the basis of its localization
pattern and interactions with peripherin-2, MREG is a likely
candidate.
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